A case of rivaroxaban associated spontaneous hemothorax

İbrahim Yıldız

doi:10.5606/tgkdc.dergisi.2019.15090

İbrahim Yıldız¹, Ebubekir Aksu², Pınar Özmen Yıldız¹, İsmail Gürbak¹

¹Department of Cardiology, Osmaniye State Hospital, Osmaniye, Turkey
²Department of Thoracic Surgery, Osmaniye State Hospital, Osmaniye, Turkey

DOI : 10.5606/tgkdc.dergisi.2019.15090

Abstract
Turkish Abstract
Full Text
Full Text PDF
Similar Articles
E-mail to Author
How to Cite

New oral anticoagulants have emerged as an alternative for warfarin for thromboembolic prevention in patients with nonvalvular atrial fibrillation. Although new oral anticoagulants have better compliance and safety margin compared to warfarin, we must be cautious with their usage. In this article, we report a case of spontaneous hemothorax related to rivaroxaban treatment. According to our research, this is the first case of spontaneous hemothorax secondary to rivaroxaban treatment.

Keywords : Hemorrhage; rivaroxaban; spontaneous hemothorax

Viewed : 3953

Downloaded : 725